# Deep Reasoning AI and Innolitics Achieve FDA 510(k) Clearance for NeuroDR, AI Software for Neurovascular CT Angiography

- Source: Business Wire
- Published: 2026-10-27T18:52:00+00:00
- Category: Business
- Original: http://www.businesswire.com/news/home/20261027339904/en/Deep-Reasoning-AI-and-Innolitics-Achieve-FDA-510-k-Clearance-for-NeuroDR-AI-Software-for-Neurovascular-CT-Angiography/?feedref=JjAwJuNHiystnCoBq_hl-WsGkFyUNMTSNrPsg57HLEqqcp-o_pnudlUwsb5apQ1S4gUE65BTfjH3-pSuqdv0gW3cb3F4oTIgUqCPafFkgu5AneicJQDNboWvodvG82E0
- Canonical: https://groundlevelnews.com/story/deep-reasoning-ai-and-innolitics-achieve-fda-510-k-clearance-for-neuro-b8c499/

SARASOTA, Fla. & AUSTIN, Texas--(BUSINESS WIRE)--Deep Reasoning AI Inc., a company founded by Cornell University artificial intelligence professors, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance (K262134) for NeuroDR, its AI-enabled software for visualizing the arteries of the head and neck from CT angiography (CTA) scans. NeuroDR was developed in collabor

_Ground Level News shows a short summary only; the full article and all rights belong to Business Wire._